The antibacterial activity against MRSA strains and other bacteria of a <500 Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae)

Microbes and Infection

Volumn 10, Issue 4, 2008, Pages 325-333

  Bexfield, Alyson ^a   Bond, A Elizabeth ^a   Roberts, Emily C ^a   Dudley, Edward ^a   Nigam, Yamni ^a   Thomas, Stephen ^b   Newton, Russell P ^a   Ratcliffe, Norman A ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b Medetec (Medical Device Technical Consultancy Services) Radyr   (United Kingdom)

Author keywords

Antibacterial; Bacterial morphology; Maggot therapy; MRSA

Indexed keywords

ANTIINFECTIVE AGENT; INSECT PROTEIN; NATURAL PRODUCT;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS CEREUS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERIOSTASIS; BACTERIUM CULTURE; COLONY FORMING UNIT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ESCHERICHIA COLI; FLOW CYTOMETRY; FLY; LUCILIA SERICATA; MAGGOT; MAGGOT THERAPY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL EXTRACTS; COLONY COUNT, MICROBIAL; DIPTERA; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; LARVA; MICROBIAL VIABILITY; MOLECULAR WEIGHT;

BACILLUS CEREUS; BACTERIA (MICROORGANISMS); CALLIPHORIDAE; DIPTERA; ESCHERICHIA COLI; LUCILIA SERICATA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NES; STAPHYLOCOCCUS AUREUS;

EID: 42649114759     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.12.011     Document Type: Article

References (31)

1. Thomas S., Jones M., and Andrews A. The use of fly larvae in the treatment of wounds. Nurs. Stand. 12 (1997) 54-59
2. Thomas S. The cost of managing chronic wounds in the UK with particular emphasis on maggot debridement therapy. J. Wound Care 15 (2006) 465-469
3. Bowler P., and Davies B.J. The microbiology of acute and chronic wounds. Wounds 11 (1999) 72-78
4. Casewell M.W., and Hill R.L. The carrier state: methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother 18 Suppl. A (1986) 1-12
5. Livermore D.M. Antibiotic resistance in staphylococci. Int. J. Antimicrob. Agents 16 (2000) S3-S10
6. Crowcroft N.S., and Catchpole M. Mortality from methicillin resistant Staphylococcus aureus in England and Wales: analysis of death certificates. BMJ 325 (2002) 1390-1391
7. Sievert D.M., Boulton M.L., Stoltman G., Johnson D., Stobierski M.G., Downes F.P., Somsel P.A., Rudrik J.T., Brown W., Hafeez W., Lundstrom T., Flanagan E., Johnson R., Mitchgell J., and Chang S. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR 51 (2002) 565-567
8. Weil G.C., Simon R.J., and Sweadner W.R. A biological, bacteriological and clinical study of larval or maggot therapy in the treatment of acute and chronic pyogenic infections. Am. J. Surg. 19 (1933) 36-48
9. Courtenay M. The use of larval therapy in wound management in the UK. J. Wound Care 8 (1999) 177-179
10. Thomas S., and Jones M. Maggots can benefit patients with MRSA. Practice Nurse 20 (2000) 101-104
11. Mumcuoglu K.Y., Miller J., Mumcuoglu M., Friger F., and Tarshis M. Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae). J. Med. Entomol. 38 (2001) 161-166
12. Simmons S.W. A bactericidal principle in excretions of surgical maggots which destroys important etiological agents of pyogenic infections. J. Bacteriol. 30 (1935) 253-267
13. Thomas S., Andrews A., Hay P., and Bourgoise S. The anti-microbial activity of maggot secretions: results of a preliminary study. J. Tissue Viability 9 (1999) 127-132
14. Bexfield A., Nigam Y., Thomas S., and Ratcliffe N.A. Detection and partial characterization of two antibacterial factors from the excretion/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus. Microb. Infect. 6 (2004) 1297-1304
15. Kerridge A., Lappin-Scott H., and Stevens J.R. Antibacterial properties of larval secretions of the blowfly, Lucilia sericata. Med. Vet. Entomol. 19 (2005) 333-337
16. Moore P.C.L., and Lindsay J.A. Molecular characterization of the dominant UK methicillin-resistant Staphylococcus aureus strains, EMRSA-15 and EMRSA-16. J. Med. Microbiol. 51 (2002) 516-521
17. Lindsay J.A., Moore C.E., Day N.P., Peacock S.J., Witney A.A., Stabler R.A., Husain S.E., Butcher P.D., and Hinds J. Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J. Bacteriol. 188 (2006) 669-676
18. Hagen R.M., Seegmuller I., Navai J., Kappstein I., Lehn N., and Miethke T. Development of a real-time PCR assay for rapid identification of methicillin-resistant Staphylococcus aureus from clinical samples. Int. J. Med. Microbiol. 295 (2005) 77-86
19. Lacy W.W., Ugaz C., and Newman E.V. The use of indigo carmine for dye dilution curves. Circ. Res. 111 (1955) 570-574
20. Pavillard E.R., and Wright E.A. An antibiotic from maggots. Nature 180 (1957) 916-917
21. Addinall S.G., Cao C., and Lutkenhaus J. Temperature shift experiments with an ftsZ84(Ts) strain reveal rapid dynamics of FtsZ localization and indicate that the Z ring is required throughout septation and cannot reoccupy division sites once constriction has initiated. J. Bacteriol. 179 (1997) 4277-4284
22. Dai K., and Lutkenhaus J. The proper ratio of FtsZ to FtsA is required for cell division to occur in Escherichia coli. J. Bacteriol. 174 (1992) 6145-6151
23. Brotz-Oesterhelt H., Beyer D., Kroll H.-P., Endermann R., Ladel C., Schroeder W., Hinzen B., Raddatz S., Paulson H., Henninger K., Bandow J.E., Sahl H.G., and Labischinski H. Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat. Med. 11 (2005) 1082-1087
24. Miller C., Thomsen L.E., Gaggero C., Mosseri R., Ingmer H., and Cohen S.N. SOS response induction by b-lactams and bacterial defense against antibiotic lethality. Science 305 (2004) 1629-1631
25. Chang T.-W., and Weinstein L. Morphological changes in Gram-negative bacilli exposed to cephalothin. J. Bacteriol. 88 (1964) 1790-1979
26. Burdash N.M., Ehrlich M.A., Ehrlich H.G., and Paris J.T. Electron microscopy of Proteus vulgaris exposed to cephalothin. J. Bacteriol. 95 (1968) 1956-1960
27. Watanakunakorn C., and Hamburger M. Induction of spheroplasts of Pseudomonas aeruginosa by carbenicillin. Appl. Microbiol. 17 (1969) 935-937
28. Yokochi T., Kusumi A., Kido N., Kato Y., Sugiyama T., Koide N., Jiang G.-Z., Narita K., and Takahashi K. Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide. Antimicrob. Agents Chemother 40 (1996) 2410-2412
29. Pankey G.A., and Sabeth L.D. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin. Infect. Dis. 38 (2004) 864-870
30. Oliver J.D. The viable but nonculturable state in bacteria. J. Microbiol. 43 (2005) 93-100
31. Suller M.T.E., and Lloyd D. Flow cytometric assessment of the postantibiotic effect of methicillin on Staphylococcus aureus. Antimicrob. Agents Chemother 42 (1998) 1195-1199